ScienceOpen:
research and publishing network
For Publishers
Discovery
Metadata
Peer review
Hosting
Publishing
For Researchers
Join
Publish
Review
Collect
My ScienceOpen
Sign in
Register
Dashboard
Blog
About
Search
Advanced search
My ScienceOpen
Sign in
Register
Dashboard
Search
Search
Advanced search
For Publishers
Discovery
Metadata
Peer review
Hosting
Publishing
For Researchers
Join
Publish
Review
Collect
Blog
About
42
views
0
references
Top references
cited by
4
0 reviews
Review
0
comments
Comment
0
recommends
+1
Recommend
0
collections
Add to
0
shares
Share
Twitter
Sina Weibo
Facebook
Email
1,361
similar
All similar
Record
: found
Abstract
: not found
Article
: not found
Treatment‐related adverse events of PD‐1 and PD‐L1 inhibitors in clinical trials: a systematic review and meta‐analysis
Author(s):
Y. Wang
,
S. ZHOU
,
F YANG
,
Wang
,
S Zhou
Publication date:
2019
Journal:
JAMA
Read this article at
ScienceOpen
Publisher
PubMed
Further versions
open (via free pdf)
oa repository (via OAI-PMH doi match)
oa repository (via pmcid lookup)
Powered by
Bookmark
There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.
Related collections
Karger: Oncology
Author and article information
Journal
DOI::
10.1001/jamaoncol.2019.0393
PubMed ID::
31697308
ScienceOpen disciplines:
Oncology & Radiotherapy
Data availability:
ScienceOpen disciplines:
Oncology & Radiotherapy
Comments
Comment on this article
Sign in to comment
scite_
Similar content
1,361
Increased CD95 (Fas) and PD‐1 expression in peripheral blood T lymphocytes in COVID‐19 patients
Authors:
Silvia Bellesi
,
Elisabetta Metafuni
,
Stefan Hohaus
…
Minimal Physiologically Based Pharmacokinetic-Pharmacodynamic (mPBPK-PD) Model of N-Acetylgalactosamine-Conjugated Small Interfering RNA Disposition and Gene Silencing in Preclinical Species and Humans.
Authors:
Vivaswath Ayyar
,
Dawei Song
,
Songmao Zheng
…
High Levels of PD-L1
+
and Hyal2
+
Myeloid-derived Suppressor Cells in Renal Cell Carcinoma
Authors:
Sergei Kusmartsev
,
Elizabeth P. Kwenda
,
Paul R Dominguez-Gutierrez
…
See all similar
Cited by
4
A systematic review on the emerging association between the occurrence of immune-related adverse events and clinical outcomes with checkpoint inhibitors in advanced cancer patients
Authors:
Alessio Cortellini
,
Sebastiano Buti
,
Veronica Agostinelli
…
A Review of Immune-Mediated Adverse Events in Melanoma
Authors:
Lucy Boyce Kennedy
,
April K S Salama
A Review About Pembrolizumab in First-Line Treatment of Advanced NSCLC: Focus on KEYNOTE Studies
Authors:
Jialin Qu
,
Li WANG
,
Man Jiang
…
See all cited by